✉news HealthMedicine first seen 49 d ago, last 11 d ago, peak #24
Moderna starts Phase 1 trial of Ebola vaccine
Original: Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna has begun a Phase 1 clinical trial of an Ebola vaccine targeting the strain behind the outbreak in the Democratic Republic of the Congo. The early-stage trial will test the vaccine candidate's safety and immune response in a small group of volunteers. The move extends the company's mRNA-based vaccine platform beyond respiratory diseases into outbreak-prone pathogens, drawing attention amid ongoing concern about Ebola flare-ups in central Africa.
Why now: News of a new vaccine trial against an Ebola strain currently driving an outbreak in the DRC is prompting fresh discussion of pandemic preparedness and mRNA technology.
ModernaEbolaDemocratic Republic of the Congo
Rank over time, top of the chart is #1. 4 snapshots from 11 d ago to 11 d ago.
Evidence
- Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak · ABC News - Breaking News, Latest News and Videos
API: https://socialmediatrends-api.osmike.com/v1/trends/42859